$IROQ
IF Bancorp, Inc.

2023 Q4 Form 10-Q Financial Statement

#000119312523274287 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $10.23M $9.291M
YoY Change 26.19% 31.27%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $165.0K $177.0K
YoY Change 5.1% 6.63%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $5.841M $4.708M
YoY Change 183.41% 468.6%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $232.0K $641.0K
YoY Change -87.72% -76.34%
Income Tax $47.00K $175.0K
% Of Pretax Income 20.26% 27.3%
Net Earnings $185.0K $466.0K
YoY Change -86.82% -76.33%
Net Earnings / Revenue 1.81% 5.02%
Basic Earnings Per Share $0.06 $0.15
Diluted Earnings Per Share $0.06 $0.14
COMMON SHARES
Basic Shares Outstanding 3.355M 3.355M
Diluted Shares Outstanding 3.208M 3.267M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.21M $38.12M
YoY Change -3.45% -10.48%
Cash & Equivalents $8.169M $13.58M
Short-Term Investments $27.04M $24.53M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $10.85M $11.01M
YoY Change 16.76% 17.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.31M $13.00M
YoY Change -4.42% 12.79%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $910.8M $870.7M
YoY Change 10.57% 7.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.084M $3.500M
YoY Change 130.21% 253.89%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $16.04M $16.00M
YoY Change 61.4% 64.61%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $20.12M $19.50M
YoY Change 1034.39% 1871.69%
LONG-TERM LIABILITIES
Long-Term Debt $34.38M $0.00
YoY Change
Other Long-Term Liabilities $6.448M $6.900M
YoY Change -15.02% -16.62%
Total Long-Term Liabilities $40.82M $6.900M
YoY Change 437.99% -16.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.12M $19.50M
Total Long-Term Liabilities $40.82M $6.900M
Total Liabilities $837.0M $804.1M
YoY Change 11.21% 8.75%
SHAREHOLDERS EQUITY
Retained Earnings $43.38M $43.16M
YoY Change 1.55% 4.56%
Common Stock $51.79M $51.69M
YoY Change 1.43% 1.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $73.74M $66.59M
YoY Change
Total Liabilities & Shareholders Equity $910.8M $870.7M
YoY Change 10.57% 7.91%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $185.0K $466.0K
YoY Change -86.82% -76.33%
Depreciation, Depletion And Amortization $165.0K $177.0K
YoY Change 5.1% 6.63%
Cash From Operating Activities $119.0K $1.001M
YoY Change -85.77% -451.23%
INVESTING ACTIVITIES
Capital Expenditures $17.00K $93.00K
YoY Change -80.23% 232.14%
Acquisitions
YoY Change
Other Investing Activities -$38.15M -$25.95M
YoY Change 130.85% 38.76%
Cash From Investing Activities -$38.17M -$26.04M
YoY Change 129.76% 39.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 32.64M 27.63M
YoY Change 154.34% -160.85%
NET CHANGE
Cash From Operating Activities 119.0K 1.001M
Cash From Investing Activities -38.17M -26.04M
Cash From Financing Activities 32.64M 27.63M
Net Change In Cash -5.409M 2.594M
YoY Change 83.79% -104.03%
FREE CASH FLOW
Cash From Operating Activities $119.0K $1.001M
Capital Expenditures $17.00K $93.00K
Free Cash Flow $102.0K $908.0K
YoY Change -86.4% -390.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
001-35226
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001514743
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
IF Bancorp, Inc.
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-1834449
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
201 East Cherry Street
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Watseka
CY2023Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2023Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60970
CY2023Q3 dei City Area Code
CityAreaCode
815
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
432-2476
CY2023Q3 dei Security12b Title
Security12bTitle
Common Stock
CY2023Q3 dei Trading Symbol
TradingSymbol
IROQ
CY2023Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3354626
CY2023Q3 us-gaap Cash And Due From Banks
CashAndDueFromBanks
13425000
CY2023Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
10717000
CY2023Q3 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
157000
CY2023Q2 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
271000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13582000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10988000
CY2023Q3 iroq Interest Bearing Time Deposits In Banks
InterestBearingTimeDepositsInBanks
1250000
CY2023Q2 iroq Interest Bearing Time Deposits In Banks
InterestBearingTimeDepositsInBanks
1250000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
191112000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
201299000
CY2023Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7450000
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7139000
CY2023Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
614598000
CY2023Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
587457000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9359000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9212000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11008000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11092000
CY2023Q3 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
4764000
CY2023Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
3127000
CY2023Q3 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
31000
CY2023Q2 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
31000
CY2023Q3 us-gaap Interest Receivable
InterestReceivable
3223000
CY2023Q2 us-gaap Interest Receivable
InterestReceivable
2781000
CY2023Q3 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
14862000
CY2023Q2 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
14761000
CY2023Q3 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
1540000
CY2023Q2 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
1482000
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12962000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11037000
CY2023Q3 us-gaap Other Assets
OtherAssets
1763000
CY2023Q2 us-gaap Other Assets
OtherAssets
3671000
CY2023Q3 us-gaap Assets
Assets
870695000
CY2023Q2 us-gaap Assets
Assets
848976000
CY2023Q3 us-gaap Demand Deposit Accounts
DemandDepositAccounts
42722000
CY2023Q2 us-gaap Demand Deposit Accounts
DemandDepositAccounts
107567000
CY2023Q3 iroq Deposits Savings Negotiable Order Of Withdrawal Now And Money Market Deposits
DepositsSavingsNegotiableOrderOfWithdrawalNowAndMoneyMarketDeposits
347552000
CY2023Q2 iroq Deposits Savings Negotiable Order Of Withdrawal Now And Money Market Deposits
DepositsSavingsNegotiableOrderOfWithdrawalNowAndMoneyMarketDeposits
344151000
CY2023Q3 us-gaap Interest Bearing Domestic Deposit Certificates Of Deposits
InterestBearingDomesticDepositCertificatesOfDeposits
270295000
CY2023Q2 us-gaap Interest Bearing Domestic Deposit Certificates Of Deposits
InterestBearingDomesticDepositCertificatesOfDeposits
264058000
CY2023Q3 iroq Brokered Certificates Of Deposit
BrokeredCertificatesOfDeposit
26579000
CY2023Q2 iroq Brokered Certificates Of Deposit
BrokeredCertificatesOfDeposit
19538000
CY2023Q3 us-gaap Deposits
Deposits
687148000
CY2023Q2 us-gaap Deposits
Deposits
735314000
CY2023Q3 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
16038000
CY2023Q2 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
10787000
CY2023Q3 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
90500000
CY2023Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
19500000
CY2023Q3 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
779000
CY2023Q2 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
1233000
CY2023Q3 us-gaap Other Postretirement Defined Benefit Plan Liabilities Current And Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesCurrentAndNoncurrent
2437000
CY2023Q2 us-gaap Other Postretirement Defined Benefit Plan Liabilities Current And Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesCurrentAndNoncurrent
2431000
CY2023Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2737000
CY2023Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1666000
CY2023Q3 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
129000
CY2023Q2 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
216000
CY2023Q3 us-gaap Other Liabilities
OtherLiabilities
4336000
CY2023Q2 us-gaap Other Liabilities
OtherLiabilities
6076000
CY2023Q3 us-gaap Liabilities
Liabilities
804104000
CY2023Q2 us-gaap Liabilities
Liabilities
777223000
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3354626
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3354626
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3354626
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3354626
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
33000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
33000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
51657000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
51543000
CY2023Q3 us-gaap Employee Stock Ownership Plan Esop Number Of Suspense Shares
EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares
149149
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Suspense Shares
EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares
153960
CY2023Q3 us-gaap Unearned Esop Shares
UnearnedESOPShares
1491000
CY2023Q2 us-gaap Unearned Esop Shares
UnearnedESOPShares
1540000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
43159000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
43365000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-26767000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21648000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
66591000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
71753000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
870695000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
848976000
CY2023Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
7733000
CY2022Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
5600000
CY2023Q3 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
1395000
CY2022Q3 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
1335000
CY2023Q3 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
26000
CY2022Q3 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
27000
CY2023Q3 iroq Federal Home Loan Bank Dividends
FederalHomeLoanBankDividends
68000
CY2022Q3 iroq Federal Home Loan Bank Dividends
FederalHomeLoanBankDividends
31000
CY2023Q3 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
69000
CY2022Q3 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
85000
CY2023Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9291000
CY2022Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
7078000
CY2023Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
3835000
CY2022Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
616000
CY2023Q3 iroq Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvances
873000
CY2022Q3 iroq Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvances
212000
CY2023Q3 us-gaap Interest Expense
InterestExpense
4708000
CY2022Q3 us-gaap Interest Expense
InterestExpense
828000
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4583000
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6250000
CY2023Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
222000
CY2022Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-88000
CY2023Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
4361000
CY2022Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
6338000
CY2023Q3 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
171000
CY2022Q3 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
173000
CY2023Q3 us-gaap Brokerage Commissions Revenue
BrokerageCommissionsRevenue
162000
CY2022Q3 us-gaap Brokerage Commissions Revenue
BrokerageCommissionsRevenue
238000
CY2023Q3 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
140000
CY2022Q3 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
177000
CY2023Q3 us-gaap Gain Loss On Sale Of Loans And Leases
GainLossOnSaleOfLoansAndLeases
72000
CY2022Q3 us-gaap Gain Loss On Sale Of Loans And Leases
GainLossOnSaleOfLoansAndLeases
42000
CY2023Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
101000
CY2022Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
97000
CY2023Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
311000
CY2022Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
328000
CY2023Q3 us-gaap Noninterest Income
NoninterestIncome
1128000
CY2022Q3 us-gaap Noninterest Income
NoninterestIncome
1218000
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3016000
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3128000
CY2023Q3 us-gaap Occupancy Net
OccupancyNet
289000
CY2022Q3 us-gaap Occupancy Net
OccupancyNet
242000
CY2023Q3 us-gaap Equipment Expense
EquipmentExpense
546000
CY2022Q3 us-gaap Equipment Expense
EquipmentExpense
566000
CY2023Q3 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
138000
CY2022Q3 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
53000
CY2023Q3 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
10000
CY2022Q3 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
21000
CY2023Q3 us-gaap Advertising Expense
AdvertisingExpense
77000
CY2022Q3 us-gaap Advertising Expense
AdvertisingExpense
101000
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
92000
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
172000
CY2023Q3 iroq Supervisory Examinations
SupervisoryExaminations
27000
CY2022Q3 iroq Supervisory Examinations
SupervisoryExaminations
45000
CY2023Q3 iroq Audit And Accounting Services
AuditAndAccountingServices
83000
CY2022Q3 iroq Audit And Accounting Services
AuditAndAccountingServices
51000
CY2023Q3 iroq Organizational Dues And Subscriptions
OrganizationalDuesAndSubscriptions
23000
CY2022Q3 iroq Organizational Dues And Subscriptions
OrganizationalDuesAndSubscriptions
22000
CY2023Q3 iroq Insurance Bond Premiums
InsuranceBondPremiums
59000
CY2022Q3 iroq Insurance Bond Premiums
InsuranceBondPremiums
53000
CY2023Q3 iroq Telephone And Postage
TelephoneAndPostage
41000
CY2022Q3 iroq Telephone And Postage
TelephoneAndPostage
41000
CY2023Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0
CY2022Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
28000
CY2023Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
447000
CY2022Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
380000
CY2023Q3 us-gaap Noninterest Expense
NoninterestExpense
4848000
CY2022Q3 us-gaap Noninterest Expense
NoninterestExpense
4847000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
641000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2709000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
175000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
740000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
466000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1969000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.2
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.2
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
466000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1969000
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-2041000
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-2268000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5121000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5688000
CY2023Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
0
CY2022Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-1000
CY2023Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-2000
CY2022Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
1000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5119000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5689000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4653000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3720000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
71753000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
466000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5119000
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.2
CY2023Q3 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
672000
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
90000
CY2023Q3 iroq Esop Shares Earned Shares
ESOPSharesEarnedShares
4811
CY2023Q3 iroq Esop Shares Earned
EsopSharesEarned
73000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
66591000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
71658000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1969000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5689000
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.2
CY2022Q3 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
667000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
449000
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
56000
CY2022Q3 iroq Esop Shares Earned Shares
ESOPSharesEarnedShares
4811
CY2022Q3 iroq Esop Shares Earned
EsopSharesEarned
91000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
67479000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
466000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
1969000
CY2023Q3 us-gaap Depreciation
Depreciation
177000
CY2022Q3 us-gaap Depreciation
Depreciation
166000
CY2023Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
222000
CY2022Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-88000
CY2023Q3 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
66000
CY2022Q3 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-110000
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
116000
CY2022Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-92000
CY2023Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
72000
CY2022Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
42000
CY2023Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0
CY2022Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
28000
CY2023Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
101000
CY2022Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
97000
CY2023Q3 us-gaap Payments To Purchase Loans Held For Sale
PaymentsToPurchaseLoansHeldForSale
3539000
CY2022Q3 us-gaap Payments To Purchase Loans Held For Sale
PaymentsToPurchaseLoansHeldForSale
1344000
CY2023Q3 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
3502000
CY2022Q3 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
1523000
CY2023Q3 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
73000
CY2022Q3 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
91000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
90000
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
56000
CY2023Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
442000
CY2022Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
306000
CY2023Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1908000
CY2022Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
53000
CY2023Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1071000
CY2022Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
31000
CY2023Q3 us-gaap Increase Decrease In Postretirement Obligations
IncreaseDecreaseInPostretirementObligations
8000
CY2022Q3 us-gaap Increase Decrease In Postretirement Obligations
IncreaseDecreaseInPostretirementObligations
6000
CY2023Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2412000
CY2022Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2187000
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1001000
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-285000
CY2023Q3 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0
CY2022Q3 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
980000
CY2023Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
3091000
CY2022Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
7201000
CY2023Q3 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
27402000
CY2022Q3 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
24872000
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
93000
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28000
CY2023Q3 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
3000
CY2022Q3 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
148000
CY2023Q3 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
1637000
CY2022Q3 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
547000
CY2023Q3 us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
0
CY2022Q3 us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
349000
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26038000
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18729000
CY2023Q3 iroq Net Increase Decrease In Demand Deposits Money Market Now And Savings Accounts
NetIncreaseDecreaseInDemandDepositsMoneyMarketNowAndSavingsAccounts
-61444000
CY2022Q3 iroq Net Increase Decrease In Demand Deposits Money Market Now And Savings Accounts
NetIncreaseDecreaseInDemandDepositsMoneyMarketNowAndSavingsAccounts
-83170000
CY2023Q3 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
13278000
CY2022Q3 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-11445000
CY2023Q3 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
-454000
CY2022Q3 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
279000
CY2023Q3 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
203500000
CY2022Q3 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
112000000
CY2023Q3 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
132500000
CY2022Q3 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
64000000
CY2023Q3 iroq Proceeds From Payments For In Securities Sold Under Agreement To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementToRepurchase
5251000
CY2022Q3 iroq Proceeds From Payments For In Securities Sold Under Agreement To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementToRepurchase
476000
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2022Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
449000
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27631000
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-45411000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2594000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-64425000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10988000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75811000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13582000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11386000
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
3637000
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
797000
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
45000
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
85000
CY2023Q3 iroq Dividend Payable
DividendPayable
672000
CY2022Q3 iroq Dividend Payable
DividendPayable
667000
CY2023Q3 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
182231
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
162986
CY2023Q3 us-gaap Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares
EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares
4811
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares
EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares
19245
CY2023Q3 us-gaap Employee Stock Ownership Plan Esop Number Of Suspense Shares
EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares
149149
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Suspense Shares
EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares
153960
CY2023Q3 us-gaap Employee Stock Ownership Plan Esop Shares In Esop
EmployeeStockOwnershipPlanESOPSharesInESOP
336191
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Shares In Esop
EmployeeStockOwnershipPlanESOPSharesInESOP
336191
CY2023Q3 us-gaap Employee Stock Ownership Plan Esop Deferred Shares Fair Value
EmployeeStockOwnershipPlanESOPDeferredSharesFairValue
2221000
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Deferred Shares Fair Value
EmployeeStockOwnershipPlanESOPDeferredSharesFairValue
2223000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
90143
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.63
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
90143
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.63
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y2M12D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
90143
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
16.63
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y2M12D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
621771000
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
56417000
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
212517000
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
99138000
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
86618000
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
29700000
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
109934000
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
594324000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
466000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1969000
CY2023Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
3354626
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
3275876
CY2023Q3 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
151554
CY2022Q3 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
170799
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3203072
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3105077
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
63681
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
76335
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3266753
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3181412
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2023Q3 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
228647000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
37535000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
191112000
CY2023Q2 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
231672000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
22000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
30395000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
201299000
CY2023Q3 iroq Debt Securities Greater Than Stated Percentage Of Equity Securities
DebtSecuritiesGreaterThanStatedPercentageOfEquitySecurities
0.10
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
0
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
0
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
5852000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
5533000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
10850000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
9659000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
11372000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
9342000
CY2023Q3 iroq Debt Securities Available For Sale Amortized Cost
DebtSecuritiesAvailableForSaleAmortizedCost
28074000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
24534000
CY2023Q3 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
228647000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
191112000
CY2023Q3 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
16000000
CY2023Q2 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
10800000
CY2023Q3 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0
CY2022Q3 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0
CY2023Q3 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0
CY2022Q3 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0
CY2023Q3 iroq Temporarily Impaired Debt Securities Percentage Of Investment Securities Portfolio
TemporarilyImpairedDebtSecuritiesPercentageOfInvestmentSecuritiesPortfolio
0.99
CY2023Q2 iroq Temporarily Impaired Debt Securities Percentage Of Investment Securities Portfolio
TemporarilyImpairedDebtSecuritiesPercentageOfInvestmentSecuritiesPortfolio
0.97
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
13575000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
493000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
175175000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
37042000
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
188750000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
37535000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
16728000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
506000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
178090000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
29889000
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
194818000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
30395000
CY2023Q3 iroq Financing Receivable Recorded Investments Past Due
FinancingReceivableRecordedInvestmentsPastDue
3154000
CY2023Q3 iroq Financing Receivable Recorded Investments Current
FinancingReceivableRecordedInvestmentsCurrent
618617000
CY2023Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
621771000
CY2023Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
594324000
CY2023Q3 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
-277000
CY2023Q2 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
-272000
CY2023Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7450000
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7139000
CY2023Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
614598000
CY2023Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
587457000
CY2023Q3 iroq Term Period On Residential Mortgage Loan
TermPeriodOnResidentialMortgageLoan
P15Y
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7139000
CY2023Q3 us-gaap Allowance For Loan And Lease Losses Period Increase Decrease
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecrease
-310000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
7000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
8000
CY2023Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7450000
CY2023Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
621771000
CY2022Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7052000
CY2023 iroq Impact Of Adopting Asu201613
ImpactOfAdoptingASU201613
47000
CY2023 us-gaap Allowance For Loan And Lease Losses Period Increase Decrease
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecrease
-52000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
51000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
39000
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7139000
CY2023Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
594324000
CY2022Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7052000
CY2022Q3 iroq Impact Of Adopting Asu201613
ImpactOfAdoptingASU201613
47000
CY2022Q3 us-gaap Allowance For Loan And Lease Losses Period Increase Decrease
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecrease
67000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
16000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
7000
CY2022Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7023000
CY2022Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
550905000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
97323000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
206439000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
100761000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
83289000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
28188000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
105771000
CY2023Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
621771000
CY2023Q3 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
25000
CY2023Q2 iroq Financing Receivable Recorded Investments Past Due
FinancingReceivableRecordedInvestmentsPastDue
981000
CY2023Q2 iroq Financing Receivable Recorded Investments Current
FinancingReceivableRecordedInvestmentsCurrent
593343000
CY2023Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
594324000
CY2023Q3 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
0
CY2023Q3 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
111000
CY2023Q2 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
0
CY2023Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
117000
CY2023Q2 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
215000
CY2023Q3 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2023 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2023Q3 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
4764000
CY2023Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
3127000
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
3843000
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
41000
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
42000
CY2023Q3 iroq Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings
-59000
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
3901000
CY2023Q3 iroq Fair Value Assets And Liabilities Measured On Recurring Basis Gain Loss Included In Earning
FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarning
59000
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
4125000
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
89000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21648000
CY2023Q3 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-5121000
CY2023Q3 iroq Other Comprehensive Income Loss Net Of Tax Portions Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionsAttributableToParent
2000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-26767000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17346000
CY2022Q3 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-5688000
CY2022Q3 iroq Other Comprehensive Income Loss Net Of Tax Portions Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionsAttributableToParent
-1000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23035000
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
171000
CY2023 iroq Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings
-101000
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues
-301000
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
3843000
CY2023 iroq Fair Value Assets And Liabilities Measured On Recurring Basis Gain Loss Included In Earning
FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarning
101000
CY2023Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
135000
CY2022Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
569000
CY2023Q3 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
8000
CY2022Q3 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
6000
CY2023Q3 iroq Income Tax Reconciliation Cash Surrender Value Life Insurance
IncomeTaxReconciliationCashSurrenderValueLifeInsurance
21000
CY2022Q3 iroq Income Tax Reconciliation Cash Surrender Value Life Insurance
IncomeTaxReconciliationCashSurrenderValueLifeInsurance
20000
CY2023Q3 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
46000
CY2022Q3 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
196000
CY2023Q3 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
23000
CY2022Q3 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
175000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
740000
CY2023Q3 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.025
CY2023Q3 iroq Maximum Asset Value Required To Be Maintained Leverage Ratio
MaximumAssetValueRequiredToBeMaintainedLeverageRatio
10000000000
CY2023Q3 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
1540000
CY2023Q2 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
1482000
CY2023Q3 iroq Mortgage Servicing Rights Fair Value Disclosure
MortgageServicingRightsFairValueDisclosure
1540000
CY2023Q3 iroq Impaired Loans Gain Losses Recognized On Assets Fair Value Disclosure
ImpairedLoansGainLossesRecognizedOnAssetsFairValueDisclosure
2361000
CY2023Q2 iroq Mortgage Servicing Rights Fair Value Disclosure
MortgageServicingRightsFairValueDisclosure
1482000
CY2023 iroq Impaired Loans Gain Losses Recognized On Assets Fair Value Disclosure
ImpairedLoansGainLossesRecognizedOnAssetsFairValueDisclosure
2361000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13582000
CY2023Q3 iroq Interest Bearing Time Deposits In Banks
InterestBearingTimeDepositsInBanks
1250000
CY2023Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
614598000
CY2023Q3 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
4764000
CY2023Q3 us-gaap Interest Receivable
InterestReceivable
3223000
CY2023Q3 us-gaap Deposits
Deposits
687148000
CY2023Q3 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
16038000
CY2023Q3 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
90500000
CY2023Q3 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
779000
CY2023Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2737000
CY2023Q3 iroq Commitments To Originate Loans
CommitmentsToOriginateLoans
0
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10988000
CY2023Q2 iroq Interest Bearing Time Deposits In Banks
InterestBearingTimeDepositsInBanks
1250000
CY2023Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
587457000
CY2023Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
3127000
CY2023Q2 us-gaap Interest Receivable
InterestReceivable
2781000
CY2023Q2 us-gaap Deposits
Deposits
735314000
CY2023Q2 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
10787000
CY2023Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
19500000
CY2023Q2 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
1233000
CY2023Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1666000
CY2023Q2 iroq Commitments To Originate Loans
CommitmentsToOriginateLoans
0
CY2023Q3 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
-88000
CY2023Q3 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
129000

Files In Submission

Name View Source Status
0001193125-23-274287-index-headers.html Edgar Link pending
0001193125-23-274287-index.html Edgar Link pending
0001193125-23-274287.txt Edgar Link pending
0001193125-23-274287-xbrl.zip Edgar Link pending
d750156d10q.htm Edgar Link pending
d750156dex311.htm Edgar Link pending
d750156dex312.htm Edgar Link pending
d750156dex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
iroq-20230930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
d750156d10q_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
iroq-20230930_lab.xml Edgar Link unprocessable
iroq-20230930_cal.xml Edgar Link unprocessable
iroq-20230930_def.xml Edgar Link unprocessable
iroq-20230930_pre.xml Edgar Link unprocessable